These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3510924)

  • 1. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry.
    Randin JP; Tappy L; Scazziga B; Jequier E; Felber JP
    Diabetes; 1986 Feb; 35(2):178-81. PubMed ID: 3510924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of glucose and lipid metabolism by continuous indirect calorimetry in Graves' disease: effect of an oral glucose load.
    Randin JP; Scazziga B; Jéquier E; Felber JP
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1165-71. PubMed ID: 3840492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and sensitivity in hyperthyroidism.
    Jap TS; Ho LT; Won JG
    Horm Metab Res; 1989 May; 21(5):261-6. PubMed ID: 2673961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-cell function and glucose and lipid oxidation in Graves' disease.
    Bech K; Damsbo P; Eldrup E; Beck-Nielsen H; Røder ME; Hartling SG; Vølund A; Madsbad S
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):59-66. PubMed ID: 8706294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease.
    Ohguni S; Notsu K; Kato Y
    Intern Med; 1995 May; 34(5):339-41. PubMed ID: 7647398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients.
    Castellino P; Luzi L; Giordano M; Defronzo RA
    J Am Soc Nephrol; 1999 May; 10(5):1050-8. PubMed ID: 10232692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral glucose metabolism in human hyperthyroidism.
    Foss MC; Paccola GM; Saad MJ; Pimenta WP; Piccinato CE; Iazigi N
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1167-72. PubMed ID: 2108183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
    Solini A; Bonora E; Bonadonna R; Castellino P; DeFronzo RA
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2552-8. PubMed ID: 9253333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
    Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanism of glucose intolerance in patients with Graves' disease].
    Kondo Y; Suzuki S; Gomi Y; Mayumi K; Sakamaki T; Inoue T; Iino S
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1257-68. PubMed ID: 1291337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
    Abbasi F; McLaughlin T; Lamendola C; Reaven GM
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
    Henry RR; Gumbiner B; Flynn T; Thorburn AW
    Diabetes; 1990 Feb; 39(2):149-56. PubMed ID: 2227122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral and hepatic insulin antagonism in hyperthyroidism.
    Shen DC; Davidson MB; Kuo SW; Sheu WH
    J Clin Endocrinol Metab; 1988 Mar; 66(3):565-9. PubMed ID: 3280588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose.
    Bonadonna RC; del Prato S; Bonora E; Gulli G; Solini A; DeFronzo RA
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E943-53. PubMed ID: 8279550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity in cardiological syndrome X.
    Quiønones Galvan A; Natali A; Muscelli E; Ciociaro D; Pecori N; Camici PG; Ferrannini E
    J Intern Med; 1996 Mar; 239(3):241-7. PubMed ID: 8772623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of ghrelin administration on glucose and lipid metabolism.
    Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
    J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.